Mar 22 | Sep 21 | Mar 21 | Sep 20 | Mar 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | € 8.81M | € 5.96M | € 17.98M | € 12.41M | € 4.61M |
Total Assets | € 1.16B | € 1.14B | € 1.13B | € 1.09B | € 1.06B |
Total Debt | € 0.00 | € 751.81M | € 0.00 | € 715.32M | € 0.00 |
Net Debt | € -8.81M | € 745.85M | € -17.98M | € 702.91M | € -4.61M |
Total Liabilities | € 847.02M | € 847.76M | € 831.46M | € 818.65M | € 764.74M |
Stockholders Equity | € 281.63M | € 261.63M | € 265.56M | € 247.81M | € 261.88M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |